Tag Archives: FDA Orphan drug status

FDA Approves New Drug for Sickle Cell Disease

Endari is the first new FDA-approved treatment in 20 years for this debilitating disease
Posted on July 12, 2017 by Kathleen Clohessy Editor-in Chief/SevenPonds

A new drug, Endari, has just received FDA approval for the treatment of sickle cell disease. The medication is the first new sickle cell therapy to be approved by the Food and Drug Administration in over 20 years. Endari is … Continue reading →

Posted in Something Special | Tagged , , , , , , | Leave a comment